 | | PATHWAY: cgh01100 | |
| Entry |
|
| Name |
Metabolic pathways - Capnocytophaga gingivalis |
| Class |
|
| Pathway map |

|
| Module |
| cgh_M00007 | Pentose phosphate pathway, non-oxidative phase, fructose-6P => ribose-5P [PATH:cgh01100] |
| cgh_M00010 | Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:cgh01100] |
| cgh_M00011 | Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:cgh01100] |
| cgh_M00053 | Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP [PATH:cgh01100] |
| cgh_M00579 | Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:cgh01100] |
| cgh_M00881 | Lipoic acid biosynthesis, plants and bacteria, octanoyl-ACP => dihydrolipoyl-E2/H [PATH:cgh01100] |
|
| Organism |
Capnocytophaga gingivalis [GN: cgh]
|
Related pathway |
| cgh00040 | Pentose and glucuronate interconversions |
| cgh00051 | Fructose and mannose metabolism |
| cgh00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
| cgh00250 | Alanine, aspartate and glutamate metabolism |
| cgh00260 | Glycine, serine and threonine metabolism |
| cgh00270 | Cysteine and methionine metabolism |
| cgh00280 | Valine, leucine and isoleucine degradation |
| cgh00290 | Valine, leucine and isoleucine biosynthesis |
| cgh00330 | Arginine and proline metabolism |
| cgh00400 | Phenylalanine, tyrosine and tryptophan biosynthesis |
| cgh00430 | Taurine and hypotaurine metabolism |
| cgh00520 | Amino sugar and nucleotide sugar metabolism |
| cgh00523 | Polyketide sugar unit biosynthesis |
| cgh00525 | Acarbose and validamycin biosynthesis |
| cgh00540 | Lipopolysaccharide biosynthesis |
| cgh00541 | Biosynthesis of various nucleotide sugars |
| cgh00630 | Glyoxylate and dicarboxylate metabolism |
| cgh00710 | Carbon fixation by Calvin cycle |
| cgh00760 | Nicotinate and nicotinamide metabolism |
| cgh00770 | Pantothenate and CoA biosynthesis |
| cgh00900 | Terpenoid backbone biosynthesis |
| cgh00999 | Biosynthesis of various plant secondary metabolites |
|
| KO pathway |
|
|
|